The Total Synthesis Of (-)-cryptocaryol A.

A stereoselective total synthesis of (-)-cryptocaryol A () is described. Key features of the 17-step route include the use of three boron-mediated aldol reaction-reduction sequences to control all stereocenters and an Ando modification of the Horner-Wadsworth-Emmons olefination that permitted the installation of the Z double bond of the α-pyrone ring.

The significance of volatile antifungal metabolites produced by trichomerma harzianum biotype Th4, in green-mould disease of commercial mushroom crops /

The aggressive mushroom competitor, Trichoderma harzianum biotype Th4, produces volatile antifungal secondary metabolites both in culture and during the disease cycle in compost. Th4 cultures produced one such compound only when cultured in the presence of Agaricus bisporus mycelium or liquid medium made from compost colonised with A. bisporus. This compound has TLC and UVabsorption and characteristics indicating that it belongs to a class of pyrone antibiotics characterised from other T. harzianum biotypes. UV absorption spectra indicated this compound was not 6-pentyl-2H-pyran-one (6PAP), the volatile antifungal metabolite widely described in Th1. Furthermore, this compound was not produced by Th1 under any culture conditions. Mycelial growth of A. bisporus, Botrytis cinerea and Sclerotium cepivorum was inhibited in the presence of this compound through volatility , diffusion and direct application. This indicates that Th4 produces novel, volatile, antifungal metabolites in the presence of A. bisporus that are likely involved in green mould disease of mushroom crops.

Synthesis of constrained tricyclic nucleosides and the core of nagilactone B

Cette thèse décrit deux thèmes principaux: 1) la conception, la synthèse, et l'évaluation biophysique des nucléosides tricycliques, et 2) la synthèse de nagilactone B, un produit naturel norditerpenoïde dilactone de la famille de produits naturels “podolactone”. Le premier chapitre décrit la stratégie de design rationnel des nucléosides nommé “restriction conformationnelle double” basée sur les études de modélisation structurales des duplex ADN–ARN modifiés. Cette stratégie implique un blocage du cycle furanose dans une configuration de type N- ou S, et une restriction de la rotation torsionelle autour de l’angle γ. La première contrainte a été incorporée avec un pont méthylène entre l’oxygène en position 2′ et le carbone 4′ du nucléoside. Cette stratégie a été inspirée par les acides nucléiques bloqués (ou “locked nucleic acid”, LNA). La deuxième contrainte a été réalisée en ajoutant un carbocycle supplémentaire dans l'échafaud de l’acide nucléique bloqué. Les défis synthétiques de la formation des nucléotides modifiés à partir des carbohydrates sont décrits ainsi que les améliorations aux stabilités thermiques qu’ils apportent aux duplex oligonucléïques dont ils font partie. Chapitres deux et trois décrivent le développement de deux voies synthétiques complémentaires pour la formation du noyau de nagilactone B. Ce produit naturel a des implications pour le syndrome de Hutchinson–Gilford, à cause de son habilité de jouer le rôle de modulateur de l’épissage d’ARN pré-messager de lamine A. Ce produit naturel contient sept stereocentres différents, dont deux quaternaires et deux comprenant un syn-1,2-diol, ainsi que des lactones à cinq ou six membres, où le cycle à six ressemble à un groupement α-pyrone. La synthèse a débuté avec la cétone de Wieland-Miescher qui a permis d’adresser les défis structurels ainsi qu’explorer les fonctionnalisations des cycles A, B et D du noyau de nagilactone B.

Bioactive pyrones and flavonoids from Cryptocarya ashersoniana seedlings

The bioassay directed fractionation of the EtOH extract from leaves of Cryptocarya ashersoniana seedlings led to the isolation of two flavonol glucosides: iso-quercitrin and hyperin, which exhibited free radical scavenging activity towards DPPH (IC50 34.4 muM and 32.7 muM, respectively) and were compared to standard compounds rutin (IC50 27.0 muM) and catechin (IC50 41.4 muM). Investigation of extracts from the seedlings roots and stems afforded one antifungal styrylpyrone: goniothalamine, and two dihydropyrones: 6-propyl-5,6-dihydro-2-pyrone and the new 6-[(4'-ethyl-9'-oxabicyclo[3.3.1]non-6'-en-3'-yl)methyl]-5,6-dihydro-2H-pyran-2-one, which had its structure determined by detailed analysis of MS and NMR data, including 2D experiments.

6-[omega-arylalkenyl]-5,6-dihydro-alpha-pyrones from Cryptocarya moschata (Lauraceae)

Eleven 6-[omega-arylalkenyl]-5,6-dihydro-alpha-pyrones, cryptomoscatones D2, E1, E2, E3 and F1 and cryptopyranmoscatones A1, A2, A3, B1, B2 and B4, in addition to goniothalamin and cryptofolione, were isolated from branch and stem bark of Cryotocarya moschata, Lauraceae. Their structures were established by spectroscopic methods. (C) 2000 Elsevier B.V. Ltd. All rights reserved.

Neolignans, styrylpyrones and flavonoids from an Aniba species

The trunk wood and barks from an Aniba species contain four esters of benzoic acid with cinnamyl alcohol, five benzofuran neolignans, licarin-A, burchellin, cis-burchellin, burchellin-rearranged and cis-burchellin-rearranged, one tetrahydrofuran neolignan, aristolignin, three bicyclooctane guianin-type neolignans, (7S, 8S, 1'R, 5'R)-4-hydroxy-3,3'-dimethoxy-4',6'-dioxo-8.1', 7.5'-neolignan-Delta: 1,3,5,2',8' and the new (7S, 8S, 1'R, 4'R, 5'S)-4'-hydroxy-3,4,3'-trimethoxy-6'-oxo-8.1', 7.5'-neolignan-Delta: 1,3,5,2',8' and (7S, 8S, 1'R, 4'R, 5'S)-4,4'-dihydroxy-3,3'-dimethoxy-6'-oxo-8.1', 7.5'-neolignan-Delta: 1,3,5,2',8', one new bicyclooctane canellin-type neolignan (7S, 8S, 1'S, 4'R, 5'R, 6'S)-4',6'-dihydroxy-3,4-dimethoxy-3'-oxo-8.1', 7.5'-neolignan-Delta: 1,3,5,8', two styrylpyrones, 4-methoxy-6-(11,12-dimethoxy-trans-styryl)-2-pyrone and 6-(11,12-methylenedioxy-trans-styryl)-4-methoxy-2-pyrone, two styrylpyrone dimers: 4'-methoxy-8-(11,12-dimethoxyphenyl)-7-[6-(4-methoxy-2-pyronyl)-6-(E)-styryl-1'-oxabicyclo[4,2,0]octa-4'-en-2'-one and the new 11,12-dimethoxyphenyl-7,7'-di-[6-(4-methoxy-2-pyronyl)]-cyclobutane and six flavonoids, 3,5-dihydroxy-7,4'-dimethoxyflavone, 5-hydroxy-3,7,4'-trimethoxyflavone, 3,5,4'-trihydroxy-7-methoxyflavone, 2,3-dihydro-5-hydroxy-7,4'-dimethoxyflavone, 2,3-dihydro-3,5-dihydroxy-7-methoxyflavone, 2,3-dihydro-3,5-dihydroxy-7,4'-dimethoxyflavone and a new flavan, 6,7,3',4',5'-pentamethoxyflavan. (C) 1997 Elsevier B.V. Ltd.

A new cytotoxic naphthopyrone dimer from Paepalanthus bromelioides

A new naphthopyrone dimer was isolated from the capitula of Paepalanthus bromelioides by chromatographic procedures. Its structure was deduced from spectrometric data. On colorimetric assay for cytotoxicity the new dimer showed IC50 of 55.9 μM. (C) 2000 Elsevier Science B.V.

Biotransformation of sucrose into 5-hydroxy-2-hydroxymethyl-γ-pirone by Aspergillus flavus

Foram investigadas a hidrólise da sacarose e a preferência pela glicose frente à frutose no processo de produção do 5-hidroxi-2-hidroximetil-γ-pirona (HHMP) na presença de Aspergillus flavus IOC 3974 cultivado em meio líquido Czapeck. Quantidades de 0,5g de pelletes foram utilizadas como inóculo. Doze frascos cônicos de 250 ml contendo 100 ml de meio de cultura com diferentes concentrações de sacarose foram utilizados. Os microrganismos foram cultivados a 120 rpm e 28"C por 16 dias sem ajuste do pH. O maior rendimento do HHMP foi 26g l^-1 em 120g l^-1 de sacarose. Nestas condições, A. flavus, foi capaz de produzir uma invertase possibilitando a hidrólise de 65% da concentração total de sacarose em 24 horas, conjuntamente com a produção de uma isomerase que foi capaz de converter a frutose em glicose. Este trabalho está focalizado preferencialmente no consumo da glicose frente à frutose por A. flavus e na estratégia de produção do HHMP.

Ação do metabólito secundário 5-hidroxi-2-hidroximetil gama-pirona isolado de fungos do gênero Aspergillus sobre monócitos humanos in vitro

O 5-hidroxi-2-hidroximetil-gama-pirona (HMP) é um metabólito secundário sintetizado por algumas espécies de fungos dos gêneros Aspergillus, Penicillium Acetobac-ter. O HMP tem várias aplicações, sendo utilizado como antioxidante, inibidor da tirosinase, agente protetor contra a radiação e antitumoral. Recentemente, foi também demonstrado que esse metabólito atua como ativador de macrófagos. No entanto, o efeito do HMP em mo-nócitos humanos é desconhecido. Assim, o objetivo deste estudo foi avaliar os efeitos de HMP sobre a viabilidade e diferenciação celular de monócitos do sangue humano in vi-tro. Leucócitos humanos do sangue periférico foram obtidos a partir de bolsas de san-gue doadas pela Fundação Centro de Hemoterapia e Hematologia do Pará (HEMOPA). O isolamento das células foi realizado por meio de gradiente de densidade com Histopaque ®1077. Os monócitos foram tratados durante 24, 48 e 72 horas com 50 e 100 μg / mL de HMP. A análise ultraestrutural dos monócitos tratados revelou que essas células apresen-tam maior espraiamento, elevado número de projeções citoplasmáticas e vacúolos, caracterís-ticas que são frequentemente observadas em células ativadas. A análise da expressão da proteína de superfície específica para macrófago (F4/80) por imunofluorescência, de-monstrou que os monócitos humanos tratados com 50 e 100 μg / mL de HMP por 48 e 72 horas, mostrou um padrão de expressão semelhante ao verificado em macrófagos humanos originados de monócitos tratados com o M-CFS. Os testes de viabilidade utilizados (Método thiazolyl blue, Potencial de membrana mitocondrial, Vermelho Neutro e Azul de Tripan) mostraram que o HMP não tem nenhum efeito citotóxico em monócitos humanos quando tra-tados com 50 e 100 μg/ mL do bioproduto. Estes resultados demonstram um novo papel pa-ra HMP como um agente imunomodulador, induzindo a diferenciação de monócitos em macrófagos.

Efeito in vitro e in vivo do 5-hidroxi-2-hidroximetil-gama-pirona durante a infecção por Leishmania (Leishmania) amazonensis

As leishmanioses são um grupo de doenças infecciosas distribuídas mundialmente. A quimioterapia é o tratamento mais eficaz para a doença; apesar do grande número de drogas antileishmania disponíveis, são usualmente tóxicas, caras e requerem um longo período de tratamento. Portanto, torna-se necessária a busca de novas substâncias que sejam capazes de atuar sobre o protozoário sem causar danos ao hospedeiro, que tenham uma via de administração não invasiva e que, ainda, sejam viáveis economicamente. O ácido kójico, ou 5-hidroxi-2-hidroximetil-γ-pirona (HMP), é conhecido por inibir a enzima tirosinase no processo de produção da melanina, sendo extensivamente utilizado em cosméticos e também como tratamento tópico para melasma, não havendo citotoxicidade em humanos; entretanto, o potencial do HMP como agente antileishmania não é conhecido. O presente estudo analisou o efeito deste bioproduto em infecções por L. amazonensis in vitro e in vivo. O HMP promoveu a diminuição do crescimento de promastigotas e amastigotas em 62% (IC₅₀ 34μg/mL) e 79% (IC₅₀ 27,84 μg/mL) in vitro, respectivamente. A análise ultraestrutural de ambas as formas evolutivas tratadas com 50 μg/mL do HMP apresentaram corpos vesiculares no interior da bolsa flagelar, induziu uma intensa vacuolização intracelular bem como alterações mitocondriais. O estudo in vitro também demonstrou que o HMP foi capaz de reverter o efeito inibitório causado pela L. amazonensis no que diz respeito à produção de radicais de oxigênio. A análise histopatológica de lesões proveniente de animais submetidos ao tratamento tópico com o HMP demonstrou que o tecido apresentou um intenso processo de cicatrização. Além disso, fibras colágenas foram encontradas de maneira organizada no local da infecção de animais tratados, com um pequeno infiltrado celular e diminuição do número de parasitos. Tendo em vista a ação seletiva do HMP in vitro, o processo de ativação da célula hospedeira pelo bioproduto e a diminuição do número de parasitos observados durante o tratamento com a pomada, e pelo fato do HMP ser amplamente utilizado como agente antimelasma em humanos, esse metabólito pode ser promissor como tratamento tópico contra a Leishmaniose cutânea e apresentando grande potencial como agente leishmanicida.

Estudo de estirilpironas de Cryptocarya mandioccana por espectrometria de massas e análise configuracional por ressonância magnética nuclear e dicroísmo circular

Pós-graduação em Química - IQ

Studies towards the total synthesis of penicillipyrone b via a biomimetic approach

Pennicillipyrone A and B are two novel meroterpenoids isolated from the marine-derived fungus Penicilliump sp. Although a preliminary toxicity studies demonstrated the bioactivity of penicillipyrone A to be far superior to that of its congener penicillipyrone B, we were intrigued by its structure. Moreover, it appeared as though one could design an efficient total synthesis based on chemistry that was familiar to our laboratory. The purpose of this project was the study of a new synthesis of Pennicillipyrone B by way of a doubley-biomimetic approach. The intended approach proceeds through a polyene cascade reaction terminated by a nucleophilic pyrone - a reaction not yet known in the literature for the construction of this type of scaffold. During the course of this study we have learned about the unanticipated reactivity of C2 substituted keto-dioxinones with regard to self-condensation. In addition, four new compounds were synthesized and two synthetic routes to the target molecule are presented.

Studies in asymmetric and heterocyclic synthesis: I. chiral ketones II. Quinolones III. Trifluoromethylated pyrones

This thesis is split into three sections based on three different areas of research. In the first section, investigations into the α-alkylation of ketones using a novel chiral auxiliary is reported. This chiral auxiliary was synthesised containing a pyrrolidine ring in the chiral arm and was applied in the preparation of α-alkylated ketones which were obtained in up to 92% ee and up to 63% yield over two steps. Both 3-pentanone and propiophenone based ketones were used in the investigation with a variety of both alkyl and benzyl based electrophiles. The novel chiral auxiliary was also successful when applied to Michael and aldol reactions. A diamine precursor en route to the chiral auxiliary was also applied as an organocatalyst in a Michael reaction, with the product obtained in excellent enantioselectivity. In the second section, investigations into potential anti-quorum sensing molecules are reported. The bacteria Pseudomonas aeruginosa is an antibiotic-resistant pathogen that demonstrates cooperative behaviours and communicates using small chemical molecules in a process termed quorum sensing. A variety of C-3 analogues of the quorum sensing molecules used by P. aeruginosa were synthesised. Expanding upon previous research within the group, investigations were carried out into alternative protecting group strategies of 2-heptyl-4-(1H)- quinolone with the aim of improving the yields of products of cross-coupling reactions. In the third section, investigations into fluorination and trifluoromethylation of 2-pyrones, pyridones and quinolones is reported. The incorporation of a fluorine atom or a trifluoromethyl group into a molecule is important in pharmaceutical drug discovery programmes as it can lead to increased lipophilicity and bioavailability, however late-stage incorporation is rarely reported. Both direct fluorination and trifluoromethylation were attempted. Eight trifluoromethylated 2-pyrones, five trifluoromethylated 2-pyridones and a trifluoromethylated 2-quinolone were obtained in a late-stage synthesis from their respective iodinated precursors using methyl fluorosulfonyldifluoroacetate as a trifluoromethylating reagent.